Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | TSC2 |
| Variant | R611Q |
| Impact List | missense |
| Protein Effect | loss of function |
| Gene Variant Descriptions | TSC2 R611Q does not lie within any known functional domains of the Tsc2 protein (UniProt.org). R611Q fails to inhibit Mtorc1 signaling in cultured cells (PMID: 31799751, PMID: 26703369, PMID: 18854862), and results in reduced interaction with Tsc1 in cultured cells (PMID: 26703369, PMID: 18854862). |
| Associated Drug Resistance | |
| Category Variants Paths |
TSC2 mutant TSC2 inact mut TSC2 R611Q |
| Transcript | NM_000548.5 |
| gDNA | chr16:g.2070571G>A |
| cDNA | c.1832G>A |
| Protein | p.R611Q |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001363528.2 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| NM_001406665.1 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| NM_021055.3 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| XM_005255529.4 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| NM_001406663.1 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| XM_005255531.4 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| NM_001114382.3 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| XM_011522637.3 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| NM_001406697.1 | chr16:g.2079579_2079580delAGinsCA | c.1831_1832delAGinsCA | p.R611Q | RefSeq | GRCh38/hg38 |
| NM_001406696.1 | chr16:g.2079579_2079580delAGinsCA | c.1831_1832delAGinsCA | p.R611Q | RefSeq | GRCh38/hg38 |
| XM_011522639.3 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| NM_001077183.2 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| XM_011522639.2 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| XM_017023616.1 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| NM_001406691.1 | chr16:g.2079579_2079580delAGinsCA | c.1831_1832delAGinsCA | p.R611Q | RefSeq | GRCh38/hg38 |
| XM_011522640.2 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| NM_000548.5 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| XM_024450413.1 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| NM_001370405.1 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| XM_011522636.2 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| NM_001406664.1 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| NM_001370404.1 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| XM_011522637.2 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| XM_017023615.1 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| XM_011522636.3 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| NM_001077183.3 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| NM_001114382.2 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| NM_001406695.1 | chr16:g.2079579_2079580delAGinsCA | c.1831_1832delAGinsCA | p.R611Q | RefSeq | GRCh38/hg38 |
| NM_000548.4 | chr16:g.2070571G>A | c.1832G>A | p.R611Q | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|